1. Testicular cancer: Determinants of cisplatin sensitivity and novel therapeutic opportunities

   de Vries, G., Rosas-Plaza, X., van Vugt, M. A. T. M., Gietema, J. A. & de Jong, S., 1-Aug-2020, In : CANCER TREATMENT REVIEWS. 88, 12 p., 102054.

   Research output: Contribution to journal › Review article › Academic › peer-review

2. Reconsider radiation exposure from imaging during immune checkpoint inhibitor trials to reduce risk of secondary cancers in long-term survivors?

   Knapen, D. G., de Groot, D. J. A., Kwee, T. C., Meijne, E. I. M., Fehrmann, R. S. N. & de Vries, E. G. E., Jul-2020, In : CANCER TREATMENT REVIEWS. 87, 4 p., 102027.

   Research output: Contribution to journal › Review article › Academic › peer-review

3. Current management of stage IV nasopharyngeal carcinoma without distant metastasis

   Ng, W. T., Corry, J., Langendijk, J. A., Lee, A. W. M., Mäkitie, A., Mendenhall, W. M., Rinaldo, A., Rodrigo, J. P., Saba, N. F., Smee, R., Strojan, P., Suárez, C., Vermorken, J. B. & Ferlito, A., Apr-2020, In : CANCER TREATMENT REVIEWS. 85, 10 p., 101995.

   Research output: Contribution to journal › Review article › Academic › peer-review

4. Primary and acquired resistance mechanisms to immune checkpoint inhibition in Hodgkin lymphoma

   Veldman, J., Visser, L., Berg, A. V. D. & Diepstra, A., Jan-2020, In : CANCER TREATMENT REVIEWS. 82, 9 p., 101931.

   Research output: Contribution to journal › Review article › Academic › peer-review

5. Clinical benefit of controversial first line systemic therapies for advanced stage ovarian cancer - ESMO-MCBS scores

   Broekman, K. E., Jalving, M., van Tinteren, H., Sessa, C. & Reyners, A. K. L., Sep-2018, In : CANCER TREATMENT REVIEWS. 69, p. 233-242 10 p.

   Research output: Contribution to journal › Review article › Academic › peer-review

View all (52) »